Aura Biosciences, Inc.AURANASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P23
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -5.29% |
| Q2 2025 | 0.69% |
| Q1 2025 | 9.84% |
| Q4 2024 | -16.37% |
| Q3 2024 | 5.32% |
| Q2 2024 | 18.73% |
| Q1 2024 | 18.57% |
| Q4 2023 | -17.41% |
| Q3 2023 | -1.86% |
| Q2 2023 | 2.32% |
| Q1 2023 | 13.13% |
| Q4 2022 | -6.47% |
| Q3 2022 | 10.59% |
| Q2 2022 | -5.05% |
| Q1 2022 | 24.31% |
| Q4 2021 | 44.19% |
| Q3 2021 | 16.64% |
| Q2 2021 | 24.51% |
| Q1 2021 | 27.53% |
| Q4 2020 | 74.90% |
| Q3 2020 | -7.13% |
| Q2 2020 | -28.49% |
| Q1 2020 | 0.00% |